Health plans explain genetic testing coverage decisions
Today there are nearly 67,000 genetic tests. With so many tests available, it can be difficult for MCOs to determine what to cover.
Read More
FDA okays targeted leukemia treatment
FDA approved a targeted new drug to treat adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia.
FDA eyes opioids in kids' medicines
An FDA committee will review prescription opioid products containing hydrocodone or codeine to treat coughs in children.
Seven things to know about Express Scripts’ plan to limit opioids
As President Trump declares the opioid epidemic “a national emergency,” a new opioid management program from Express Scripts will limit the number and strength of opioid drugs to first-time patients.
Opinion: 4 reasons to revitalize the Children’s Health Insurance Program
As legislative discussions begin regarding the reauthorization of CHIP, it is imperative to keep in mind how proposed cuts could be detrimental to the health and future of our nation’s children.
Four innovative ways employers can deliver healthcare
A National Business Group on Health survey finds that with costs continuing to rise, employers are shifting control efforts to how healthcare is delivered and paid for.
Report sheds light on regional diabetes prevalence, cost
A new report by the Blue Cross Blue Shield Association has eye-opening findings about diabetes prevalence, severity and cost.
Four reasons payers need to embrace the digital economy
Consumer and provider expectations have changed as a result of the digital economy. Here are four reasons why payers need to start migrating their businesses in that direction.
Groups praise lawsuit against Walgreens, CVS
Pharmacy and medical organizations lauded a new class action lawsuit against CVS Health and Walgreens, alleging the two pharmacy chains colluded with pharmacy benefit managers (PBMs) to drive up the cost of generic drugs.
FDA warns about contaminated drugs, dietary supplements
FDA warned consumers and health care professionals not to use a certain brand of drugs and dietary supplements that are contaminated.
Non-adherence has big impact on Medicaid beneficiaries with HIV
New data presented at the International AIDS Society Conference examines the medical and financial burden of missing pills.
How Cigna reduced opioid use 12% in 12 months
Managed Healthcare Executive (MHE) recently spoke with Cigna’s Chief Medical Officer for Behavioral Health Doug Nemecek, MD, about Cigna’s efforts, outcomes, and how it plans to reach its goal
How medical schools are responding to the opioid epidemic
As the opioid epidemic rages, up-and-coming physicians are seen as part of the solution. Here’s how medical schools are changing their training programs.
Nine new skills needed by health execs
Do you have what it takes to succeed as a healthcare executive? Industry leaders weigh in.
Opinion: Three ways to maximize the benefits of physician assistants
How Phoenix Children’s improved access, value and outcomes through a dedicated focus on advanced practice providers.
Opinion: Medicare for all: Imminent or pipe dream?
As the nation debates the future of our healthcare system, one idea gaining attention is a “Medicare-for-all” single-payer national health insurance plan.
DEA wants to slash opioid production
The Drug Enforcement Administration wants to slash the production of opioid painkillers by 20% in 2018.
Four data analytics areas that promote cost savings
Analytics is an integral component of healthcare no matter what Congress decides, according to one expert. Here are 4 areas of data analytics that health plans can develop that will promote future cost savings.
Medical marijuana update: Top 3 things health execs should know
Here’s what you need to know about medical marijuana laws, and what they mean for the healthcare system.
FDA approves novel leukemia, hepatitis C drugs
FDA approved the first treatment for patients with a certain type of acute myeloid leukemia, as well as 2 new drugs to treat hepatitis C.
Controversy surrounds Exondys 51 approval: What to know
New medicine for Duchenne muscular dystrophy raises questions. Here’s whose covering it and why.
Eight data analytics terms every healthcare executive should know
With so much going on in health IT, it can be difficult to keep track of all the buzzwords. Here’s your quick and easy guide.
Brace for a barrage of biosimilars
The next few years will see the healthcare industry bracing itself for new biosimilar products for a range of illnesses from oncology to rheumatoid arthritis.
How to approach value in oncology
An eye-opening study by Precision for Value assesses cancer value frameworks.
Three ways integration focuses on customers
Here are three ways HealthPartners’ health plan and care delivery system work together to save customers time and money and improve their experience.
4 things to know about second failed GOP healthcare bill
Here’s a look at four changes in the second round of healthcare bill revisions that just weren’t enough to muster up enough votes.
Regular use of low-dose aspirin may lower breast cancer risk
The medication’s ability to reduce inflammation sited as one possible explanation.
Depression: How to treat, avoid misdiagnosis
Depression is one of the most common diagnosed disorders but providers still have trouble diagnosing and treating these patients.
Number of women with metastatic breast cancer rising, as is survival rate
Study highlights the need for services and research for this understudied population.
Pop health dashboard gives U.S. cities access to key data
An initiative that aims to expand the use of population health strategies has received funding to be used in 500 U.S. cities.
